For those you can't be bothered to click.
From bub's Q3 FY21 report today ------
Delivered quarter-on-quarter growth in 3 strategic priority areas of business vs. Q2 FY21:
• Bubs® Total Infant Formula; up +4% QoQ
• China Export Sales; up +28% QoQ (Bubs® Infant Formula CBEC sales; up +47% QoQ)
• Daigou Channel; up +19% QoQ (Bubs® Infant Formula Daigou sales; up +38% QoQ)
--------------------------------------
Hopefully that translate to A2M doing just as well.
For those you can't be bothered to click.From bub's Q3 FY21...
-
- There are more pages in this discussion • 5,705 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.77 |
Change
0.130(1.96%) |
Mkt cap ! $4.894B | |||
| Open | High | Low | Value | Volume |
| $6.63 | $6.77 | $6.63 | $10.00M | 1.485M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2420 | $6.76 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.77 | 37726 | 4 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| A2M (ASX) Chart |